Explore
Validate
Learn60065-1-Ig
antibody from Proteintech Group
Targeting: CXCR3
CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [12]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 60065-1-Ig - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#60065-1-Ig, RRID:AB_2292376
- Product name
- CXCR3B-specific antibody
- Antibody type
- Monoclonal
- Description
- KD/KO validated CXCR3B-specific antibody (Cat. #60065-1-Ig) is a mouse monoclonal antibody that shows reactivity with human and has been validated for the following applications: FC, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1B2D6
- Vial size
- 20ul, 150ul
Submitted references Genistein suppresses allergic contact dermatitis through regulating the MAP2K2/ERK pathway.
CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
CXCL12-CXCL4 heterodimerization prevents CXCL12-driven breast cancer cell migration.
The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells.
Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.
Expression of E-cadherin and specific CXCR3 isoforms impact each other in prostate cancer.
Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis.
Differential regulation of pericyte function by the CXC receptor 3.
Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
A novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation.
Pericyte regulation of vascular remodeling through the CXC receptor 3.
Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.
Xu J, Xiong H, Zhao Z, Luo M, Ju Y, Yang G, Mei Z
Food & function 2021 May 21;12(10):4556-4569
Food & function 2021 May 21;12(10):4556-4569
CXCL11 promotes tumor progression by the biased use of the chemokine receptors CXCR3 and CXCR7.
Puchert M, Obst J, Koch C, Zieger K, Engele J
Cytokine 2020 Jan;125:154809
Cytokine 2020 Jan;125:154809
CXCL12-CXCL4 heterodimerization prevents CXCL12-driven breast cancer cell migration.
Nguyen KTP, Druhan LJ, Avalos BR, Zhai L, Rauova L, Nesmelova IV, Dréau D
Cellular signalling 2020 Feb;66:109488
Cellular signalling 2020 Feb;66:109488
The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells.
Kundu N, Ma X, Brox R, Fan X, Kochel T, Reader J, Tschammer N, Fulton A
Breast cancer : basic and clinical research 2019;13:1178223419873628
Breast cancer : basic and clinical research 2019;13:1178223419873628
Innate lymphocyte-induced CXCR3B-mediated melanocyte apoptosis is a potential initiator of T-cell autoreactivity in vitiligo.
Tulic MK, Cavazza E, Cheli Y, Jacquel A, Luci C, Cardot-Leccia N, Hadhiri-Bzioueche H, Abbe P, Gesson M, Sormani L, Regazzetti C, Beranger GE, Lereverend C, Pons C, Khemis A, Ballotti R, Bertolotto C, Rocchi S, Passeron T
Nature communications 2019 May 16;10(1):2178
Nature communications 2019 May 16;10(1):2178
Expression of E-cadherin and specific CXCR3 isoforms impact each other in prostate cancer.
Ma B, Khazali A, Shao H, Jiang Y, Wells A
Cell communication and signaling : CCS 2019 Dec 12;17(1):164
Cell communication and signaling : CCS 2019 Dec 12;17(1):164
Upregulation of angiostatic chemokines IP-10/CXCL10 and I-TAC/CXCL11 in human obesity and their implication for adipose tissue angiogenesis.
Hueso L, Ortega R, Selles F, Wu-Xiong NY, Ortega J, Civera M, Ascaso JF, Sanz MJ, Real JT, Piqueras L
International journal of obesity (2005) 2018 Aug;42(8):1406-1417
International journal of obesity (2005) 2018 Aug;42(8):1406-1417
Differential regulation of pericyte function by the CXC receptor 3.
Bodnar RJ, Wells A
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2015 Nov-Dec;23(6):785-96
Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society 2015 Nov-Dec;23(6):785-96
Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, Li Y, Yang G
Human pathology 2015 Dec;46(12):1872-80
Human pathology 2015 Dec;46(12):1872-80
A novel CXCR3-B chemokine receptor-induced growth-inhibitory signal in cancer cells is mediated through the regulation of Bach-1 protein and Nrf2 protein nuclear translocation.
Balan M, Pal S
The Journal of biological chemistry 2014 Feb 7;289(6):3126-37
The Journal of biological chemistry 2014 Feb 7;289(6):3126-37
Pericyte regulation of vascular remodeling through the CXC receptor 3.
Bodnar RJ, Rodgers ME, Chen WC, Wells A
Arteriosclerosis, thrombosis, and vascular biology 2013 Dec;33(12):2818-29
Arteriosclerosis, thrombosis, and vascular biology 2013 Dec;33(12):2818-29
Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion.
Wu Q, Dhir R, Wells A
Molecular cancer 2012 Jan 11;11:3
Molecular cancer 2012 Jan 11;11:3
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The CXCR3B-specific antibody from Proteintech is a mouse monoclonal antibody to a peptide of human CXCR3B-specific. This antibody recognizes human antigen. The CXCR3B-specific antibody has been validated for the following applications: ELISA, WB analysis.
